Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AZD7442
AZD7442
AstraZeneca antibody cocktail slashes risk of symptomatic COVID-19, setting up regulatory filings and a lifeline for the immunosuppressed
Fierce Biotech
Fri, 08/20/21 - 10:53 am
AstraZeneca
antibodies
COVID-19
clinical trials
AZD7442
AstraZeneca's Covid-19 antibody cocktail misses the mark in preventing symptoms post-exposure
Endpoints
Tue, 06/15/21 - 10:45 am
AstraZeneca
monoclonal antibodies
AZD7442
COVID-19
clinical trials
As data near, U.K. rethinks AstraZeneca COVID-19 antibody deal
Fierce Biotech
Wed, 05/12/21 - 10:49 am
AstraZeneca
UK
COVID-19
antibodies
AZD7442